EFG Asset Management (Americas)’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,500
| Closed | -$202K | – | 134 |
|
|
2024
Q1 | $202K | Sell |
7,500
-4,472
| -37% | -$120K | 0.06% | 125 |
|
|
2023
Q4 | $359K | Sell |
11,972
-868
| -7% | -$26K | 0.08% | 118 |
|
|
2023
Q3 | $263K | Buy |
12,840
+1,129
| +10% | +$23.1K | 0.06% | 131 |
|
|
2023
Q2 | $233K | Buy |
11,711
+829
| +8% | +$16.5K | 0.05% | 134 |
|
|
2023
Q1 | $186K | Buy |
+10,882
| New | +$186K | 0.04% | 134 |
|